Analyst consensus rating
Ocugen Analyst Rating: none
OCGN is rated none by 6 analysts with a $12.17 target. As of 2026-08-26.
Direct answer
Ocugen's consensus rating is none.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.17.
Forecast evidence checked August 26, 2026.
Get free Ocugen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.40
- Average price target
- $12.17
- High price target
- $22.00
- Low price target
- $8.00
- Low target gap
- +471.4%
- Target upside
- +769%
- High target gap
- +1,471.4%
- Target range width
- 1,000%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Ocugen?
Ocugen has a verified none consensus. The same dataset has an average price target of $12.17.
How far are Ocugen's low and high targets from the recorded price?
The low target implies +471.4%, while the high target implies +1,471.4%.
How many analysts are included in Ocugen's consensus?
The verified consensus includes 6 analysts.
How is Ocugen's target upside or downside calculated?
The average target of $12.17 is divided by the recorded price of $1.40, then one is subtracted to produce +769%. This does not guarantee a future return.
When was Ocugen's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.